Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Subdermal progestin implant contraception.

¹University of California, San Francisco.

Current Opinion in Obstetrics & Gynecology

|August 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2007

Same author

Contraception-associated menstrual problems: etiology and management.

Dialogues in contraception·2002

Same author

Practice guidelines for OC selection: update.

Dialogues in contraception·2002

Same author

Implant contraception.

Seminars in reproductive medicine·2001

Same author

Misoprostol: a boon to safe motherhood...or not?

Lancet (London, England)·2001

Same author

Time to pardon the IUD?

The New England journal of medicine·2001

Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026

Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026

Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026

Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026

Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026

Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026

See all related articles

New sustained-release progestin contraceptives offer effective, reversible birth control with fewer health risks than traditional methods. These systems provide stable hormone levels, improving user acceptance despite common side effects like irregular bleeding.

Area of Science:

Reproductive Health
Pharmacology
Contraception

Background:

Growing global demand for more effective and acceptable birth control methods.
Limitations of traditional oral and injectable contraceptives, including hormonal peaks and associated health risks.
Need for long-acting, reversible contraceptive options with improved safety profiles.

Purpose of the Study:

To review the development and characteristics of sustained-release progestin contraceptive systems.
To compare the benefits and drawbacks of these novel systems against existing methods.
To highlight the potential of future sustained-release progestin contraceptives.

Main Methods:

Review of existing literature and clinical data on sustained-release progestin contraceptives.

Keywords:

Biodegradable Delivery Systems Biology Contraception Contraceptive Agents, Female--administraction and dosage Contraceptive Agents, Female--pharmacodynamics Contraceptive Agents, Progestin--administraction and dosage Contraceptive Agents, Progestin--pharmacodynamics Contraceptive Agents--administraction and dosage Contraceptive Agents--pharmacodynamics Contraceptive Effectiveness Contraceptive Implants--beneficial effects Contraceptive Implants--indications Contraceptive Methods--beneficial effects Contraceptive Methods--indications Economic Factors Family Planning Levonorgestrel--administraction and dosage Levonorgestrel--pharmacodynamics Lipid Metabolic Effects Lipids Physiology Research And Development Reversibility Technology

Related Experiment Videos

Analysis of delivery systems including subdermal implants, injections, intrauterine devices, and vaginal rings.

Examination of the pharmacological profile of synthetic progestins used in these systems.

Main Results:

Sustained-release systems provide low, stable progestin levels, enhancing efficacy and safety by avoiding hormonal peaks and estrogen use.
Common side effects include irregular menstrual bleeding, but overall user acceptability remains high.
The Norplant system (levonorgestrel implants) is an approved example, with other systems in development.

Conclusions:

Sustained-release progestin contraceptives represent a significant advancement in birth control technology.
These methods offer a highly effective, convenient, and reversible option with a favorable safety profile.
Future developments promise a wider range of long-acting contraceptive choices for women.